Coegin Pharma advanced its peptide-based hair growth and skin pigmentation projects, improved its financial position, and secured key partnerships, but faces material uncertainty regarding future financing beyond Q4 2025.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.